Cutaneous angiosarcoma. Analysis of 434 cases from the Surveillance, Epidemiology, and End Results Program, 1973-2007

被引:122
|
作者
Albores-Saavedra, Jorge [1 ,2 ]
Schwartz, Arnold M. [3 ]
Henson, Donald E. [4 ]
Kostun, Lara [4 ]
Hart, Alexandra [4 ]
Angeles-Albores, David [1 ,2 ]
Chable-Montero, Fredy [1 ,2 ]
机构
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Pathol, Mexico City 14000, DF, Mexico
[2] Med Sur Clin & Fdn, Mexico City 14000, DF, Mexico
[3] George Washington Univ Hosp, Dept Pathol, Washington, DC 20037 USA
[4] George Washington Canc Inst, Washington, DC 20037 USA
关键词
Cutaneous angiosarcoma; Anatomical site; Histologic grade; Survival rate; COMPLICATING XERODERMA-PIGMENTOSUM; EPITHELIOID ANGIOSARCOMA; SOFT-TISSUE; RETINOBLASTOMA; DIAGNOSIS; SARCOMAS; SCALP; RISK; SKIN;
D O I
10.1016/j.anndiagpath.2010.07.012
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Cutaneous angiosarcoma is an aggressive malignant mesenchymal vasoformative neoplasm that accounts for 1% of all soft tissue sarcomas. Using data from the National Cancer Institute's Surveillance, Epidemiology, and End Results program, we analyzed the demographics and survival of cutaneous angiosarcoma. The Surveillance, Epidemiology, and End Results program recorded 434 cases of cutaneous angiosarcoma from 1973 to 2007. The incidence was nearly the same in men (222 cases) and women (212 cases). Most patients were white (88%) with a mean age of 73 years. African Americans made up only 4% of the cases. Two hundred seventy (62%) cases were tumors of the head and neck, whereas 106 (24%) cases arose in the skin of the trunk. Grade was recorded in 194 cases (45%): 28 were grade 1, 44 were grade 11, 60 were grade III, and 62 were grade IV. Survival rates of cutaneous angiosarcoma correlated with age, anatomical site, and stage of disease. Patients younger than 50 years had a 10-year relative survival rate of 71.7%, whereas patients 50 years and older had a 36.8% 10-year survival rate. Tumors of the scalp and neck resulted in a 13.8% 10-year relative survival rate, whereas tumors arising in the trunk resulted in a 75.3% 10-year survival rate. Tumors localized to the skin had better prognosis (53.6% 10-year relative survival rate) than those with regional or distant stage (19.0% and 6.2%). Twenty-six percent of patients with angiosarcoma had a prior primary. Cutaneous angiosarcomas arise predominantly in the head and neck of white individuals older than 60 years. (C) 2011 Elsevier Inc. All rights reserved.
引用
收藏
页码:93 / 97
页数:5
相关论文
共 50 条
  • [21] Cutaneous soft tissue sarcoma incidence patterns in the surveillance, epidemiology, and end results program, 1978-2004: An analysis of 12,114 cases
    Rouhani, P.
    Fletcher, C. D.
    Devesi, S.
    Toro, J. R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 : S87 - S87
  • [22] Osteosarcoma: a Surveillance, Epidemiology, and End Results program-based analysis from 1975 to 2017
    Cole, Sarah
    Gianferante, D. Matthew
    Zhu, Bin
    Mirabello, Lisa
    CANCER, 2022, 128 (11) : 2107 - 2118
  • [23] Breast Angiosarcoma Incidence and Outcomes: An Analysis from Surveillance Epidemiology End Result Database
    Yuen, Ashley
    Bains, Kirandeep K.
    Sidhwa, Feroze
    Misra, Subhasis
    Bibi, Palwasha
    Ullah, Asad
    Ahmed, Zanati M.
    Matolo, Nathaniel M.
    Waheed, Abdul
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S51 - S51
  • [24] TRENDS IN SURVIVAL OF PATIENTS WITH GLIOBLASTOMA MULTIFORME: SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS (SEER) PROGRAM 1973-2005
    Harraher, Ciara
    Norden, Andrew
    Claus, Elizabeth
    NEURO-ONCOLOGY, 2009, 11 (05) : 585 - 585
  • [25] Cancer survival and incidence from the surveillance, epidemiology, and end results (SEER) program
    Ries, LAG
    Reichman, ME
    Lewis, DR
    Hankey, BF
    Edwards, BK
    ONCOLOGIST, 2003, 8 (06): : 541 - 552
  • [26] Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program
    Vakharia, Paras P.
    Kelm, Ryan C.
    Orrell, Kelsey A.
    Patel, Kevin R.
    Singam, Vivek
    Ali, Yasmeen
    Rastogi, Supriya
    Yousif, Rame
    Rangel, Stephanie M.
    West, Dennis P.
    Nardone, Beatrice
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2020, 59 (04) : 463 - 468
  • [27] Prostate Cancer Modality Time Trend Analyses From 1973 to 2004 A Surveillance, Epidemiology, and End Results Registry Analysis
    Jani, Ashesh B.
    Johnstone, Peter A. S.
    Liauw, Stanley L.
    Master, Viraj A.
    Rossi, Peter J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 168 - 172
  • [28] Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases
    Kevin C. Lee
    Sung-Kiang Chuang
    Elizabeth M. Philipone
    Scott M. Peters
    Head and Neck Pathology, 2019, 13 : 378 - 385
  • [29] Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases
    Lee, Kevin C.
    Chuang, Sung-Kiang
    Philipone, Elizabeth M.
    Peters, Scott M.
    HEAD & NECK PATHOLOGY, 2019, 13 (03): : 378 - 385
  • [30] Dysembryoplastic Neuroectodermal Tumor: An Analysis from the Surveillance, Epidemiology, and End Results Program, 2004-2013
    Ha Son Nguyen
    Ninh Doan
    Gelsomino, Michael
    Shabani, Saman
    WORLD NEUROSURGERY, 2017, 103 : 380 - 385